Company / Income Tax per Share
Acadia Pharmaceuticals Income Tax per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
-$1.51
FY2025
5-year range
-$1.51 / $0.19
FY2021-FY2025
Trend
-887.3%
vs FY2024
Sector context
#198 of 201
Health Care
What the data says
Income Tax per Share changed -887% YoY in FY2025, a notable deviation from the 9-year average annual change of +10%.
Based on SEC 10-K filings.
-1.51 in FY2025.
Improved from $0.06 to $-1.51 over the past 2 years.
Health Care sector context is included.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 1% in Health CareTop 1% of 201This company -$1.51 Sector average $1.35
▼
-212.2% below sector average
Key checks
Key Insights
- In FY2025, income tax per share decreased 887.3% year-over-year.
- Ranks #198 out of 201 companies in the Health Care sector.
- Peak income tax per share was recorded in FY2024.
Company context
Key Data Points
- Strong profit margin: 24.9%
- Low earnings quality (accrual-heavy earnings)
- Strong return on equity: 28.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.51 | -887.3% |
| FY2024 | $0.19 | +203.7% |
| FY2023 | $0.06 | +302.3% |
| FY2022 | $0.02 | +614.9% |
| FY2021 | $0.00 | -44.1% |
| FY2020 | $0.00 | -35.4% |
| FY2019 | $0.01 | -39.7% |
| FY2018 | $0.01 | +9.5% |
| FY2017 | $0.01 | -29.9% |
| FY2016 | $0.01 | +298.8% |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026